The findings revealed that the overexpression of FLT3LG in tumor cells effectively impeded tumor growth, augmented the proliferation of CD4+ and CD8+ T cells, suppressed the activity of Treg cells, and significantly potentiated the efficacy of anti-PD-1 therapy. The gene discussed is CD8A; the disease is neoplasm.